KLEANTHIS G XANTHOPOULOS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for KLEANTHIS G XANTHOPOULOS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of KLEANTHIS G XANTHOPOULOS. KLEANTHIS G XANTHOPOULOS is a Director in APRICUS BIOSCIENCES, INC. ($APRI) and a President and CEO in Regulus Therapeutics Inc. ($RGLS) and a in Zosano Pharma Corp ($ZSAN) and a Director in Zosano Pharma Corp ($ZSAN).
Address: C/O ANADYS PHARMACEUTICALS, INC. 9050 CAMINO SANTA FE SAN DIEGO 92121 CA
Companies in which KLEANTHIS G XANTHOPOULOS is an Insider
Regulus Therapeutics Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KLEANTHIS G XANTHOPOULOS: President and CEO
Holdings: 3,705 shares
Current Value: $5,187
Latest Transaction: Apr 21 2015
$RGLS Market Capitalization: $72.77M
$RGLS Previous Close: $1.40
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SEELOS THERAPEUTICS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KLEANTHIS G XANTHOPOULOS: Director
Holdings: 24,575 shares
Current Value: $64,632
Latest Transaction: Jan 08 2018
$SEEL Market Capitalization: $20.96M
$SEEL Previous Close: $2.63
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Zosano Pharma Corp
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KLEANTHIS G XANTHOPOULOS: Director
Holdings: 23,596 shares
Current Value: $28,315
Latest Transaction: Jun 14 2021
$ZSAN Market Capitalization: $19.67M
$ZSAN Previous Close: $1.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of KLEANTHIS G XANTHOPOULOS
Sentiment: All, RGLS, SEEL, ZSAN
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 14 2021 | ZSAN | Zosano Pharma Corp | XANTHOPOULOS KLEANTHIS G | Director | Option Exercise | A | 0.93 | 30,000 | 27,954 | 30,000 | |
| Jun 14 2021 | ZSAN | Zosano Pharma Corp | XANTHOPOULOS KLEANTHIS G | Director | Grant | A | 0.00 | 15,000 | 0 | 23,596 | 8.6 K to 23.6 K (+174.50 %) |
| Jun 29 2020 | ZSAN | Zosano Pharma Corp | XANTHOPOULOS KLEANTHIS G | Grant | A | 0.00 | 7,500 | 0 | 8,596 | 1.1 K to 8.6 K (+684.31 %) | |
| Jun 05 2020 | ZSAN | Zosano Pharma Corp | XANTHOPOULOS KLEANTHIS G | Director | Option Exercise | A | 1.01 | 15,000 | 15,150 | 15,000 | |
| Jul 18 2019 | ZSAN | Zosano Pharma Corp | XANTHOPOULOS KLEANTHIS G | Director | Option Exercise | A | 2.34 | 1,500 | 3,510 | 1,500 | |
| Jun 01 2018 | ZSAN | Zosano Pharma Corp | XANTHOPOULOS KLEANTHIS G | Director | Option Exercise | A | 4.24 | 25,000 | 106,000 | 25,000 | |
| Mar 02 2018 | ZSAN | Zosano Pharma Corp | XANTHOPOULOS KLEANTHIS G | Director | Option Exercise | A | 0.53 | 30,000 | 15,900 | 30,000 |